Syncona Limited — Regulatory Filings 2018

Dec 17, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7019K

Syncona Limited

17 December 2018

Syncona Limited

Change of Registered Office

17 December 2018

Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life science, announces that its registered office has changed to: 8 Bloomsbury St, London, WC1B 3SR, UK.

[ENDS]

Enquiries

Syncona Ltd

Annabel Clay  

Tel: +44 (0)20 3981 7928     

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com  

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

CROFKODQDBDDPBD